STARS + Maternal Support for Substance Use During Pregnancy
Trial Summary
What is the purpose of this trial?
This study is evaluating a randomized clinical trial and a quasi-experimental observational study combined. Pregnant women with substance abuse issues are referred to the Substance Use Treatment and Recovery (STAR) prenatal clinic, and those who consent to participate in the study will be randomized to the STAR + maternal Attachment Biobehavioral Catchup (mABC) home visiting model or to the STAR only treatment group. Those who opt out of receiving prenatal care at STAR will be recruited as a control group for the QED portion. Those randomized to STAR + mABC will receive additional supports from a licensed therapist, including up to 12 home visits focused on substance exposed babies and positive parenting.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the STARS + maternal Attachment Biobehavioral Catchup home visiting model treatment for substance use during pregnancy?
Research shows that home visitation programs, like the Parent-Child Assistance Program, help at-risk mothers reduce substance use and improve outcomes for their children. Additionally, attachment-based parenting programs have been shown to enhance supportive parenting behaviors in mothers with substance-use problems.12345
Is the STARS + Maternal Support for Substance Use During Pregnancy treatment safe for humans?
The research articles provided do not contain specific safety data for the STARS + Maternal Support for Substance Use During Pregnancy treatment. However, they discuss related programs that integrate maternity care and substance use treatment, which have shown positive outcomes in terms of reducing child maltreatment and improving social-emotional functioning, suggesting a focus on safety and well-being.678910
How is the STARS + Maternal Support treatment different from other treatments for substance use during pregnancy?
The STARS + Maternal Support treatment is unique because it combines the STARS Program, which focuses on substance use treatment and recovery, with the maternal Attachment Biobehavioral Catchup (mABC) home visiting model. This approach not only addresses substance use but also enhances maternal sensitivity and involvement, which are crucial for improving attachment and developmental outcomes in children.346911
Research Team
David Bard, PhD
Principal Investigator
OUHSC
Eligibility Criteria
This trial is for pregnant women in the Oklahoma City area who are dealing with substance abuse during pregnancy, can understand English, and are eligible for services at the STAR prenatal clinic. Women must be able to read English at an 8th-grade level or higher to participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive prenatal care services in the STAR clinic, with some randomized to receive additional mABC home visiting services
Follow-up
Participants are monitored for outcomes such as mother depressive symptoms, child development, and child welfare involvement
Extension
Optional continued support and monitoring for families at risk under the Family First Prevention Services Act
Treatment Details
Interventions
- STARS + maternal Attachment Biobehavioral Catchup home visiting model
- STARs Only
STARS + maternal Attachment Biobehavioral Catchup home visiting model is already approved in United States for the following indications:
- Substance use disorder treatment for pregnant women
- Support for substance-exposed newborns
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor